baber/WOPTO huggingface dataset:
Patent BE-1005334-A0 (BE)
Title: Machine tournante a engrenages helicoidaux comportant une protection etanche de l'accouplement du rotor a son organe d'entrainement.
Inventor: PAPIN JEAN-PAUL
IPC: H02K7/10
Filed: 1990-07-31
Abstract: Machine tournante du type à deux engrenages hélicoïdaux intérieurs l'un à l'autre, dont l'engrenage hélicoïdal interne, tournant, ou rotor (1) possède une dent de moins que l'engrenage hélicoïdal externe fixe, cette machine comportant en outre un organe d'entraînement en rotation (2) et des moyens d'accouplement dutype cardan (1a, 3-5) interosés entre l'organe d'entraînement et le rotor, ainsi que des moyens de protection étanche de l'accouplement vis-à-vis de l'environnement, comprenant : un bloc massif (8) en élastomère en forme de disque épais possédant un alésage central axial (9), monté sur l'extrémité qu'il enserre de façon étanche, de l'organe d'entraînement située à proximité de l'accouplement ; une bague rigide de protection (6) entourant la périphérie du bloc (8) et d'une portion adjacente du rotor (1) incorporant les moyens d'accouplement, et des moyens pour assurer l'étanchéité entre ladite bague et, d'une part, le bloc, et , d'autre part, le rotor.
Patent IL-62880-A0 (IL)
Title: Imidazolyl-vinyl ketones and carbinols,their preparation and their use as fungicides
IPC: A01N43/50
Filed: 1981-05-15
Abstract: Imidazolyl-vinyl ketones or carbinols of the formula   <IMAGE>   in which A represents a keto group or a CH(OH) grouping, R1 represents an alkyl or halogenoalkyl radical and R2 represents an alkyl radical, an optionally substituted cycloalkyl or cycloalkenyl radical, a halogenoalkyl, alkoxyalkyl, alkylmercaptoalkyl, dialkylaminoalkyl or hydroxyalkyl radical, an optionally substituted alkenyl, alkinyl or alkeninyl radical, a phenylalkyl radical which is optionally substituted in the alkyl part and in the phenyl part, an optionally substituted indenyl or fluorenyl radical or an optionally substituted diphenylmethyl or triphenylmethyl radical, or acid addition products and metal salt complexes thereof which possess fungicidal activity.
Patent IL-72076-A0 (IL)
Title: 1-acetonyl-2-(phenylimino)-imidazolidines and acid addition salts thereof,their preparation and pharmaceutical compositions containing them
IPC: C07D405/12
Filed: 1984-06-12
Abstract: Compounds of the formula   <IMAGE>   wherein X, Y and Z are each independently hydrogen, halogen, lower alkyl, halo(lower alkyl), lower alkoxy, halo(lower alkoxy), (lower alkyl)thio or halo(lower alkyl)thio, or Y and Z, together with each other, are lower alkylenedioxy; and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as analgesics.
Patent IL-79123-A0 (IL)
Title: Method of stabilizing electrochemical primary cells having reactive anodes of zinc,aluminum or magnesium,a stabilized anode obtained by said method and a cell including such an anode
IPC: H01M4/06
Filed: 1986-06-16
Abstract: The invention provides a method of stabilizing a primary electrochemical cell which includes at least one reactive anode made of a metal selected from the group constituted by zinc, aluminum, and magnesium, the method consisting in adding a stabilizer to said electrode, the stabilizer concentration lying in the range 0.001% to 1% by weight of electrode metal, and the stabilizer comprising at least one alkyl and polyethoxylalcohol sulfide satisfying the following formula: R-S-(CH2)2-(O-CH2-CH2-)n-OH (1) in which: R is an alkyl radical which may optionally be branched, an aryl radical, or an alkylaryl radical; and n lies in the range 2 to 100. The invention also provides an anode obtained by the above method, and a primary electrochemical cell having an alkaline or a saline electrolyte and including such an anode.
Patent IL-95269-A0 (IL)
Title: Diarylacetylenes,their preparation and pharmaceutical compositions containing them
IPC: A61P37/00
Filed: 1990-08-02
Abstract: Diarylacetylenes of the formula I   <IMAGE> I  where R1 is hydrogen or C1-C4-alkyl, R2 and R3 are each hydrogen or, when R1 is hydrogen, together form a -C(CH3)2-B-C(CH3)2- group (where B is -CH2Ch2- or -CH(CH3)-) or -OC(Ch3) (Z)CH2CH2- group (where Z is C1-C2-alkyl) or R2 is C1-C3-alkoxy and R3 is C1-C10-alkyl or, when R2 is hydrogen, R1 and R3 are each alkyl as defined above, R4 is C1-C6-alkyl and n is 0, 1 or 2, are prepared as described and used as active compounds in drugs and cosmetics.
Patent FI-20011813-A0 (FI)
IPC: H04W88/18
Filed: 2001-09-14
Abstract: A method and apparatus for processing messages relate to controlling, filtering and directing SMS-(short message service) and corresponding messages. In a user-specific way. According to the method and apparatus, SMS-(short message service) messages and/or MMS-(multimedia messaging service) messages are processed in a gateway and the invention comprises the steps of classifying the messages, based on their characteristics and processing the classified messages based on processing code that takes the classification into account. The step of processing the classified messages comprises directing the messages further according to the processing instructions.
Patent FI-20021576-A0 (FI)
Inventor: HEIKKILAE ISMO
IPC: B41F33/00
Filed: 2002-09-04
Abstract: An apparatus and a method for measuring print quality in a printing press used in newspaper production, wherein the measuring apparatus measures several parallel reflection profiles extending in the longitudinal direction simultaneously across the entire width of a paper web and the measurement results of the measuring apparatus are used for the detection of waste and for the adjustment of inking in the printing press in real time.
Patent FI-20030176-A0 (FI)
IPC: E01F9/615
Filed: 2003-02-05
Abstract: A flight obstacle light fitting having a tubular body (1) provided with light emitting semiconductor light sources (3), such as LEDs or emitters, fitted around it on its outer circumference at at least one level and provided with directional lenses, oriented horizontally outwards. The tubular body (1) is completely open at both ends to allow more efficient cooling, and the tubular body (1) has a polygonal outer surface, providing an even mounting surface for the light sources, especially to permit more efficient transfer of heat to the body.
Patent IL-100293-A0 (IL)
Title: Stabilization of 3-isothiazolones by certain hydrazide compounds
IPC: A61K8/49
Filed: 1991-12-09
Abstract: Composition comprising (A) 3-isothiazolone antimicrobial compound, (B) an amount of a hydrazide-containing compound to stabilize said 3-isothiazolone, and method of stabilizing 3-isothiazolone antimicrobial compound, and method of use to inhibit growth of bacteria, fungi, algae, and yeast at a locus.
Patent IL-102574-A0 (IL)
Title: Process for chiral thiazolidine-2,4-dione hypoglycemics and intermediates
IPC: C07D417/10
Filed: 1992-07-21
Abstract: A process for the stereoselective preparation of intermediates in the preparation of potent, chiral thiazolidine-2,4-dione hypoglycemics.
Patent IL-105193-A0 (IL)
Title: Fluorinated hydroxyalkylquinoline acids and pharmaceutical compositions containing them
IPC: C07D215/12
Filed: 1993-03-29
Abstract: Compounds having the formula I: <CHEM> are leukotriene antagonists and inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection.
Patent IL-106558-A0 (IL)
Title: Novel glycoforms of soluble complement receptor 1
IPC: C07K14/705
Filed: 1993-08-02
Abstract: Provided are methods of making preparations of recombinant soluble Complement Receptor type 1 (sCR1) defined with respect to the distribution of sCR1 glycoforms and therapeutic methods using them. The preparations are suitable for treatment of allograft or xenograft rejection, diseases involving inflammation or inappropriate complement activation, and thrombotic or shock state conditions. Preferred methods employ sCR1 glycoforms that are sialylated, have a pI of </=5.1, or have a sialic acid: mannose molar ratio of >/=0.25.
Patent IL-115321-A0 (IL)
Title: Thromboresistant surface treatment for biomaterials
IPC: A61F2/06
Filed: 1995-09-15
Abstract: A biomaterial with a thromboresistant surface and a method for forming same are provided. The thromboresistant surface is comprised of a distinct coating layer of a chitosan-based membrane and a bioactive material. The bioactive material is capable of converting the chitosan membrane coating from a highly thrombogenic to an essentially non-thrombogenic one. The bioactive material can be a polymeric substance, such as polyvinyl alcohol, forming a polymeric blend with the chitosan, or, can be a biological substance, such as serum albumin, embedded in or attached to the chitosan membrane which has been activated with a treatment of glutardialdehyde. The thromboresistant biomaterial is suitable for use in vascular grafts having an inside diameter of less than 6 millimeters.
Patent IL-144500-A0 (IL)
Title: A method for coating a substrate using a medium temperature chemical vapor deposition process
IPC: C23C16/36
Filed: 2000-02-24
Abstract: The present invention comprises a method for coating at least one substrate with a carbonitride-containing coating by a MT CVD process which includes heating a substrate or substrates to a reaction temperature in a reaction chamber and then introducing into the reaction chamber a deposition process gas comprising from about 1 to about 30% of a hydrogen halide and predetermined amounts of a carbon/nitrogen source, a metal-halogen compound, H2, and optionally N2 so that a layer of the carbonitride-containing coating deposits on the surface of the substrates or substrates. The present invention also includes embodiments for coating at least one substrate with a carbonitride-containing coating by a MT CVD process which includes maintaining a temperature gradient in the reaction chamber during the introduction of the deposition process gas into the reaction chamber. Carbonitride-containing coatings that may be applied by the method include carbonitrides, oxycarbonitrides, and borocarbonitrides of Ti, Hf, Zr, V, Nb, and Ta and their mixtures and alloys.
Patent IL-147490-A0 (IL)
Title: Preparation of phenylphosphate esters of 4,4'-biphenol
IPC: C07F9/14
Filed: 2002-01-06
Abstract: A process for preparing 4,4'-biphenol phenylphosphate ester products is described. These ester products, having low acid value and low contents of phenol and residual catalyst, being flowable powders, and further having excellent physical properties such as heat and hydrolytic stability, are useful as halogen-free, effective flame retardants, particularly in thermoplastic polymer compositions.
Patent IL-158311-A0 (IL)
Title: Fast analog sampler with great memory depth
IPC: G11C27/04
Filed: 2002-04-24
Abstract: An analog sampler for recording analog data carried by a bus includes an array of recording cells arranged in rows and columns. Each cell has an analog input coupled to the bus by a switch having a controlling digital input. A delay line is associated with each column, coupled to a shift register. Successive outputs of the line are coupled to each of the digital inputs of the cells of the column such that at any moment there is no more than one switch of a single recording switch. The signal is thus not disrupted by noise.
Patent IL-166451-A0 (IL)
Title: A process for the preparation of 5-(2'pyridyl)-2-pyridone derivatives
IPC: C07D213/69
Filed: 2005-01-23
Abstract: The present invention provides a method of industrially and advantageously producing a 5-(2'-pyridyl)-2-pyridone derivative. The present invention relates to a production method of a 5-(2'-pyridyl)-2-pyridone derivative represented by the formula (VI), which includes reacting a pyridine derivative of the formula (I) with a brominating agent to give a 5-bromopyridine derivative of the formula (II), reacting the obtained 5-bromopyridine derivative with a metallizing agent to give an organometallic compound of the formula (III), reacting the obtained organometallic compound with a 2-sulfonylpyridine derivative of the formula (IV) to give a 6-alkoxy-3,2'-bipyridine derivative of the formula (V) and hydrolyzing the obtained 6-alkoxy-3,2'-bipyridine derivative: <CHEM> <CHEM> wherein each symbol is as defined in the Description.
Patent IL-177335-A0 (IL)
Title: Magnetic manipulation of biological samples
IPC: C12N5/00
Filed: 2006-08-07
Abstract: The invention relates to a cell carrier (10) for receiving a biological sample. The carrier comprises a magnetic element (20) and a floor element (30) that forms a stable support (31) that can be displaced on a solid base surface in at least one direction. The invention also relates to a manipulation device for biological samples and to a method for manipulating biological samples.
Patent IL-182431-A0 (IL)
Title: Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
Filed: 2007-04-10
Abstract: The invention relates to compounds of the formula (I)   
wherein 
n 
is 0, 1 or 2; 
G 
is CH 2  or CHR 3 ; 
R 1  
is H, C 1 -C 6 -alkyl, C 1 -C 6 -alkyl substituted by C 3 -C 6 -cycloalkyl, C 1 -C 6 -hydroxyalkyl, fluorinated C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, fluorinated C 3 -C 6 -cycloalkyl, C 3 -C 6 -alkenyl, fluorinated C 3 -C 6 -alkenyl, formyl, acetyl or propionyl; 
R  2  R 3  and R 4  
are, independently of each other, H, methyl, fluoromethyl, difluoromethyl, or trifluoromethyl; 
A 
is phenylene, pyridylene, pyrimidylene, pyrazinylene, pyridazinylene or thiophenylene, which can be substituted by one ore more substituents selected from halogen, methyl, methoxy and CF 3 ; 
E 
is NR 5  or CH 2 , wherein R 5  is H or C 1 -C 3 -alkyl; 
Ar 
is a cyclic radical selected from the group consisting of phenyl, a 5- or 6-membered heteroaromatic radical comprising as ring members 1, 2 or 3 heteroatoms selected from N, O and S and a phenyl ring fused to a saturated or unsaturated 5- or 6-membered carbocyclic or heterocyclic ring, where the heterocyclic ring comprises as ring members 1, 2 or 3 heteroatoms selected from N, O and S and/or 1, 2 or 3 heteroatom-containing groups each independently selected from NR 8 , where R 8  is H, C 1 -C 4 -alkyl, fluorinated C 1 -C 4 -alkyl, C 1 -C 4 -alkylcarbonyl or fluorinated C 1 -C 4 -alkylcarbonyl, and where the cyclic radical Ar may carry 1, 2 or 3 substituents R a , wherein the variable R a  has the meanings given in the claims and in the description;  
and physiologically tolerated acid addition salts thereof.  The invention also relates to the use of a compound of the formula I or a pharmaceutically acceptable salt thereof for preparing a pharmaceutical composition for the treatment of a medical disorder susceptible to treatment with a dopamine D3 receptor ligand.
Patent IL-183991-A0 (IL)
Title: Method for processing images using automatic georeferencing of images derived from a pair of images captured in the same focal plane
IPC: G06T17/05
Filed: 2007-06-17
Abstract: An image processing system in which the georeferencing of at least one digital image is achieved by means of at least one picture model of the said digital image and of a digital reference relief form. The digital image is obtained from a pair of digital images acquired in the same focal plane. An intermediate digital relief form is produced from said pair of digital images. The intermediate digital relief form and said digital reference relief form are processed to refine the said picture model of the said digital image to be georeferenced. A final digital relief form is generated and said final digital relief form and said digital image are projected in a geographical or cartographic system, for the purpose of their georeferencing. The pair of digital images in the same focal plane are acquired in a small stereoscopic base configuration by sensors located in the same focal plane.
Patent IL-195719-A0 (IL)
Title: Enriched infant formulas
IPC: A23L33/00
Filed: 2008-12-04
Abstract: Disclosed are infant formulas comprising, on an as-fed basis (A) at least about 5 mg/L of gangliosides, (B) at least about 150 mg/L of phospholipids, (C) lactoferrin, and (D) at least about 70 mg/L of sialic acid, with at least about 2.5% by weight of the sialic acid as lipid-bound sialic acid. From about 50% to 100% by weight of each of the gangliosides, phospholipids, lactoferrin, and sialic acid is provided by an enriched whey protein concentrate, with the concentrate representing at least about 6.5 g/L of the formula on an as-fed basis. Also disclosed are methods of using the formula to reduce the risk of diarrhea infants, and to produce a gut microflora profile similar to that of breast-fed infants.
Patent RO-126855-A0 (RO)
Title: Process for attaching reinforced concrete elements to already made strength structure elements without metal connection members
Inventor: CIORAN CONSTANTIN
IPC: E04C5/16
Filed: 2011-06-21
Abstract: The invention relates to a process for attaching reinforced concrete elements to the already made strength structure elements, without metal connection members, meant to arrange and reinforce a civil building to be used for dwelling, commercial or social-cultural purposes. According to the invention, the process consists in manufacturing a polystyrene plate (1) of necessary dimensions, cutting some fiberglass meshes (2 and 3) necessary to reinforce the upper and the lower sides, respectively, covering the polystyrene plate (1) with the fiberglass meshes (2 and 3) which have the upper and lower ends bent and which are attached with adhesive mortar for polystyrene, at an attaching end, the pocket of a compression core (4) is filled with mortar and finally, after 1-2 days from the manufacture, when the mortar is dry, there is carried out a shelf which is fixed with mortar, by means of some mounting supports, to a wall in the desired place, and when the mortar attachment is dry, after 2 days, the supports are removed and the shelf remains attached.
Patent RO-127378-A0 (RO)
Title: Topical composition for the treatment of skin wounds, burns and ulcerations and process for preparing the same
Inventor: AXINTE MIHAELA
IPC: A61K9/06
Filed: 2011-12-21
Abstract: The invention relates to a pharmaceutical composition for the treatment of wounds and burns and to a process for preparing the same. According to the invention, the composition comprises 0.1...5% silver sulphadiazine, 0.5...30% bentonite, 0.1...5% chitosan, 0...50% glycerol and 0.1...5% lactic acid, the percentage being expressed by mass. The process claimed by the invention consists in heating a mixture of purified water and lactic acid, to a temperature of 70...80°C, admixing chitosan while stirring continuously for 20 min, the mixture being then cooled down to a temperature of 30...35°C and the resulting gel being added to a mixture of bentonite and glycerol, after which the suspension formed of silver sulphadiazine and glycerine is admixed thereto while stirring for 20...30 min for the product homogenization.
Patent AP-2001002109-A0 (AP)
Title: Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin.
Inventor: GROVE WILLIAM RICHARD
IPC: A61K33/243
Filed: 1999-07-08
Abstract: Acetyldinaline in combination with gemcitabine, a pharmaceutically acceptable salt thereof, capecitabine, or cisplatin is synergistic treating cancer.
Patent IE-910189-A1 (IE)
Title: Chelants
IPC: C07D471/18
Filed: 1991-01-21
Abstract: There are provided novel chelating agents useful in the preparation of contrast media for diagnostic imaging or of radiotherapeutic or detoxification compositions.
Patent MA-23745-A1 (MA)
Inventor: VOLKER BREU
IPC: C07D213/40
Filed: 1995-12-15
Abstract: Compounds of formula I wherein R1 signifies phenyl, substituted phenyl or heterocyclyl; R2 signifies phenyl or substituted phenyl; R3 signifies hydrogen, lower-alkyl, cyano, carboxy, esterified carboxy, phenyl, substituted phenyl, heterocyclyl or a residue -CONR5R6 or -NR5COR7; R4 signifies hydrogen or lower-alkyl; R5 signifies hydrogen or a residue R7, and R6 signifies -(CH2)mR7; or R5 and R6 together with the N atom associated with them signify a heterocyclic residue; R7 signifies phenyl, substituted phenyl, cycloalkyl, heterocyclyl, lower-alkyl, cyano-lower-alkyl, hydroxy-lower-alkyl, di-lower-alkylamino-lower-alkyl, carboxy-lower-alkyl, lower-alkoxycarbonyl-lower-alkyl, lower-alkoxycarbonylamino-lower-alkyl or phenyl-lower-alkoxycarbonyl; Ra signifies hydrogen, lower-alkyl or hydroxy; Rb signifies hydrogen or lower-alkyl; Z signifies hydroxy, amino or a residue -OR8, -OC(O)NHR8, -OC(O)OR8, -NHC(O)NHR8 or -NHC(O)OR8; R8 signifies heterocyclyl, phenyl, substituted phenyl or lower-alkyl; A and Y each independently signify oxygen or sulphur, X signifies nitrogen or CH; m signifies 0, 1 or 2; and n signifies 0, 1 or 2; and pharmaceutically usable salts thereof are inhibitors of endothelin receptors. They can therefore be used for the treatment of disorders which are associated with endothelin activities, especially circulatory disorders such as hypertension, ischaemia, vasospasms and angina pectoris.
Patent MA-27747-A1 (MA)
Title: Dérivés azabicycliques à substituants pyridyloxyméthyle et benzisoxazole
Inventor: BRIGHT GENE MICHAEL
IPC: C07D487/04
Filed: 2005-09-12
Abstract: Dérivés azabicycliques à substituants pyridyloxymethyle et benzisoxazole Un composé azabicyclique à substituant aminométhylpyridyloxyméthyle/benzisoxazole répondant à la formule (I), une composition pharmaceutique le comprenant, et une méthode de traitement d'un ou de plusieurs troubles du SNC ou d'autres troubles, y compris le traitement conjoint de troubles tels que la schizophrénie et la dépression. Ou son énantiomère (R) ou (S), ou son isomère cis ou trans, ou un sel, produit de solvatation ou précurseur médicamenteux pharmaceutiquement acceptable, de celui-ci ou de n'importe laquelle des entités précédentes, formule dans laquelle m est égal à 0 ou 1, Z représente un groupe (II) dans lequel R7 représente un atome d'hydrogène ou un groupe alkoxy en C1 à C3 ; R8 représente un atome d'hydrogène, un groupe hydroxy ou alkoxy en C1 à C3 ; et R9 représente un groupe alkoxy en C1 à C3 ; X représente un atome d'oxygène ou un groupe NR, dans lequel R représente un atome d'hydrogène ou un groupe alkyle en C1 à C6 ; Y représente un groupe méthylène, lorsque n est égal à 0, 1. ou 2 ; ou un atome d'oxygène, d'azote ou de soufre, lorsque n est égal à 2, 3 ou 4 ; R1 et R2 représentent chacun indépendamment un atome d'hydrogène, un atome d'halogène ou un groupe alkyle en C1 à C6, alkoxy en C1 à C6 ou (alkoxy en C1 à C6) (alkyle en C1 à C6), n'importe lequel de ces groupes pouvant être non substitué ou substitué avec un ou plusieurs halogènes.
Patent MA-20150128-A1 (MA)
Title: Procédés d'exploitation d'accumulation réduite d'hydrocarbure résiduel pendant un traitement de schiste pétrolifère
Inventor: PATTEN JAMES W
IPC: E21B43/34
Filed: 2013-06-13
Abstract: La présente invention concerne un procédé de réduction d'accumulation d'hydrocarbure résiduel pendant un traitement, pouvant faire appel à la formation d'un corps perméable (608) d'une matière hydrocarbonée fragmentée dans une enceinte (602). Selon l'invention, un système de collecte de liquide primaire (610) est situé dans une partie inférieure du corps perméable. Le système de collecte de liquide primaire (610) comporte une surface supérieure destinée à collecter et éliminer des liquides. La matière hydrocarbonée fragmentée qui se trouve sous le système de collecte de liquide primaire (610) forme une zone de non-production (616). Au moins une partie du corps perméable (608) est chauffée à une température massique supérieure à une température de production suffisante à en éliminer les hydrocarbures à l'intérieur d'une zone de production (614), les conditions dans la zone de non-production (616) étant maintenues en-deçà de la température de production.